Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery.
about
Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant.Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimensComparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
P2860
Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@en
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@nl
type
label
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@en
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@nl
prefLabel
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@en
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@nl
P2093
P2860
P1433
P1476
Biosimilars of filgrastim in a ...... fects on bone marrow recovery.
@en
P2093
Adrian Tempescul
Christian Berthou
Françoise Ngo Sack
Gaelle Guillerm
Jean-Christophe Ianotto
Marie-Anne Couturier
Nathalie Mugnier
Pascal Delepine
P2860
P356
10.3109/10428194.2013.791984
P577
2013-06-05T00:00:00Z